05-22-2008: Lab901 Ltd. announced that it has signed a distribution deal with the Korean PCR diagnostics firm Seegene Inc. Under the deal, Lab901 has appointed Seegene as its exclusive diagnostics distributor for the ScreenTape® system in the Korean market. The parties will also co-market their ScreenTape® and Seeplex® products in the global multiplex PCR diagnostics market.
Richard Rowling, Lab901's Director of Sales & Marketing said "Lab901 is delighted to have secured this deal with Seegene. Combining Seegene's highly multiplexed PCR diagnostic kits with Lab901's simple and convenient automated analysis instrument will bring a great boost to both companies' global sales"
ISO 9001 Accreditation Enhances Lab901’s Reputation for Quality
Lab901 announced that it has been awarded ISO 9001:2008 accreditation for manufacturing quality covering its ScreenTape® System for automated gel electrophoresis. ISO 9001:2008 addresses quality management systems and looks at, among other things, what an organisation does to fulfil a custo ... more
Lab901 and Biofortuna to collaborate on automated PCR Dx for HLA and Coeliac disease
Lab901 and Biofortuna announced that they will collaborate on the launch of an automated PCR Dx system for the rapid detection of certain HLA-related diseases such as coeliac disease. Lab901 will be optimising its automated ScreenTape® PCR diagnostics platform for use with Biofortuna’s ran ... more
Successful £2.4m funding round takes Lab901 Limited to the next level
Lab901 Limited has successfully raised £2.4 million in equity funding. This latest vote of confidence comes from Lab901's strong consortium of UK investors, comprising Archangel Informal Investment Ltd, Alliance Trust Equity Partners (ATEP), Scottish Enterprise SVF, Foresight 3 VCT plc and ... more
Seegene and Molzym partner on automated molecular sepsis diagnostics
Seegene and Molzym announced a partnership on the automated Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens. "The Magicplex Sepsis Test will be the new gold standard for performing accurate, rapi ... more
Seegene Awarded Patent for Haplotyping Using Multiplex PCR
Seegene, Inc announced that it has been awarded international patent protection for a break-through technology able to accelerate the detection of highly personal variations in genetic sequences. These genetic variations can identify an individual's risks for a broad range of disorders, suc ... more
Seegene and Shimadzu Agree to Join Multi-Pathogen Tests and Platform for Combined Analytics Solution
Seegene, Inc. and Shimadzu Corporation announced a strategic partnership to combine Seegene's Seeplex(R) multi-pathogen tests with Shimadzu's MultiNA (1) analytical platform. Under terms of the deal, Shimadzu and Seegene will collaborate on integrating the Seeplex polymerase chain reaction- ... more
About analytica-world.com
analytica-world.com is the industry portal of the international trade fair analytica, which is organized by Messe München. It features useful information about markets, trends and innovations. It is operated by CHEMIE.DE, one of analytica's official sales partners.
Advertising at analytica-world.com
Our advertising formats support you in getting your message across to a clearly defined target audience.
The global network of analytica trade fairs:
